Here, we identified, for the first time, that PRLR-SF reduces nucleotide synthesis in PDAC cells via the Hippo pathway, which inhibits the pentose phosphate pathway (PPP) to prevent PDAC cell proliferation and tumor growth. Here, PRLR is linked to neoplasm.